Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan S Zager

Showing results (31-40 of 321) with videos related to

Pageof 33
Sort By:
Clinical & Experimental Metastasis|May 9, 2018
Regional therapies for locoregionally advanced and unresectable melanomaEvan S Weitman, Jonathan S Zager
Annals of Surgical Oncology|August 29, 2018
ASO Author Reflections: Resection Margins in Merkel Cell Carcinoma: Is a 1 cm Margin Wide Enough?Matthew C Perez, Jonathan S Zager
Clinical & Experimental Metastasis|February 22, 2022
Introduction: Novel Frontiers in Cancer MetastasisStanley P Leong, Jonathan S Zager
Clinical & Experimental Metastasis|December 8, 2023
Management of melanoma: can we use gene expression profiling to help guide treatment and surveillance?Jonathan S Zager, David M Hyams
Melanoma Management|December 7, 2019
Locoregional melanoma: identifying optimal care in a rapidly changing landscapeDavid E Gyorki, Jonathan S Zager
Melanoma Management|December 7, 2019
Intra-arterial perfusion-based therapies for regionally metastatic cutaneous and uveal melanomaKristy K Broman, Jonathan S Zager
The Surgical Clinics of North America|November 23, 2019
Management of Locoregionally Advanced MelanomaDavid T Pointer, Jonathan S Zager
Annals of Surgical Oncology|December 3, 2009
Who is to blame for false-negative sentinel node biopsies in melanoma?Vernon K Sondak, Jonathan S Zager
Cancer Control : Journal of the Moffitt Cancer Center|June 27, 2009
Melanoma: promising new discoveries and treatment modalities for difficult clinical scenarios - part IIJonathan S Zager, Jeffrey S Weber
The Surgical Clinics of North America|September 24, 2014
Locoregional therapies in melanomaAndrea M Abbott, Jonathan S Zager
Pageof 33

Showing results (31-40 of 321) with videos related to

Sort By:
Pageof 33
Clinical & Experimental Metastasis|May 9, 2018
Regional therapies for locoregionally advanced and unresectable melanomaEvan S Weitman, Jonathan S Zager
Annals of Surgical Oncology|August 29, 2018
ASO Author Reflections: Resection Margins in Merkel Cell Carcinoma: Is a 1 cm Margin Wide Enough?Matthew C Perez, Jonathan S Zager
Clinical & Experimental Metastasis|February 22, 2022
Introduction: Novel Frontiers in Cancer MetastasisStanley P Leong, Jonathan S Zager
Clinical & Experimental Metastasis|December 8, 2023
Management of melanoma: can we use gene expression profiling to help guide treatment and surveillance?Jonathan S Zager, David M Hyams
Melanoma Management|December 7, 2019
Locoregional melanoma: identifying optimal care in a rapidly changing landscapeDavid E Gyorki, Jonathan S Zager
Melanoma Management|December 7, 2019
Intra-arterial perfusion-based therapies for regionally metastatic cutaneous and uveal melanomaKristy K Broman, Jonathan S Zager
The Surgical Clinics of North America|November 23, 2019
Management of Locoregionally Advanced MelanomaDavid T Pointer, Jonathan S Zager
Annals of Surgical Oncology|December 3, 2009
Who is to blame for false-negative sentinel node biopsies in melanoma?Vernon K Sondak, Jonathan S Zager
Cancer Control : Journal of the Moffitt Cancer Center|June 27, 2009
Melanoma: promising new discoveries and treatment modalities for difficult clinical scenarios - part IIJonathan S Zager, Jeffrey S Weber
The Surgical Clinics of North America|September 24, 2014
Locoregional therapies in melanomaAndrea M Abbott, Jonathan S Zager
Pageof 33